[Treatment of acute lymphoblastic leukemia during a remission by irradiation of the central nervous system and subsequent administration of 8 chemotherapeutic agents].
D000293:Adolescent; D000328:Adult; D000470:Alkaloids / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D001389:Azirines / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000532:radiotherapy; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000470:Alkaloids; D000970:Antineoplastic Agents; D001389:Azirines; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001379:Azathioprine; D011241:Prednisone; D008727:Methotrexate
Traitement de la leucémie aiguë lymphoblastique pendant une rémission par l'irradiation  du système nerveux central et l'administration successive de cures de huit composés chimiothérapiques.